86 related articles for article (PubMed ID: 1093667)
21. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.
Falkson G; van Dyk JJ; van Eden EB; van der Merwe AM; FALKSON HC
Cancer Chemother Rep; 1974; 58(6):939-41. PubMed ID: 4615788
[No Abstract] [Full Text] [Related]
22. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
Netter A; Netter AL; Gorins A
Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
[No Abstract] [Full Text] [Related]
23. [Treatment of parkinsonian syndromes by bromocriptin].
Gautier JC; Durand JP
Nouv Presse Med; 1977 Jan; 6(3):171-4. PubMed ID: 319421
[TBL] [Abstract][Full Text] [Related]
24. Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
Medina D
J Natl Cancer Inst; 1977 Apr; 58(4):1107-10. PubMed ID: 576622
[TBL] [Abstract][Full Text] [Related]
25. [Bromocriptine in chemotherapy-resistant, metastatic breast cancer. Results of the GO-MC-BROMO 2/82 AIO Study].
Holtkamp W; Nagel GA
Onkologie; 1988 Jun; 11(3):121-7. PubMed ID: 3045725
[TBL] [Abstract][Full Text] [Related]
26. Use of ergot derivative lisuride in Parkinson's disease.
Suchy I; Horowski R
Adv Neurol; 1984; 40():515-21. PubMed ID: 6695629
[No Abstract] [Full Text] [Related]
27. [Therapy of acromegaly using bromocriptine].
Köbberling J; Schwinn G; Dirks H
Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
Falkson G; Van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
[No Abstract] [Full Text] [Related]
29. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
Schellekens LA; Roland R; Lequin RM
Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
[No Abstract] [Full Text] [Related]
30. [Advanced prostatic cancer: therapeutic modalities].
Faul P; Altwein JE
Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1975-80. PubMed ID: 6391887
[No Abstract] [Full Text] [Related]
31. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
[TBL] [Abstract][Full Text] [Related]
32. [1st experiences in the treatment of ovarian tumors with Peptichemio].
Natale N; Mangioni C; Remotti G
Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
[No Abstract] [Full Text] [Related]
33. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
Boyd AE; Reighlin S
N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
[No Abstract] [Full Text] [Related]
34. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
[TBL] [Abstract][Full Text] [Related]
35. [Drug therapy of acromegaly using bromocriptine: results after a 1-year therapy].
Benker G; Zäh W; Günnewig H; Hackenberg K; Werner U; Reinwein D
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1899-901. PubMed ID: 801096
[No Abstract] [Full Text] [Related]
36. Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
Ward HW
Clin Oncol; 1977 Mar; 3(1):91-5. PubMed ID: 862280
[No Abstract] [Full Text] [Related]
37. [Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination].
Mussa A; Dogliotti L; Di Carlo F
Minerva Med; 1977 Jun; 68(32):2233-44. PubMed ID: 577604
[TBL] [Abstract][Full Text] [Related]
38. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
Delitala G; Masala A; Alagna S; Devilla L
IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
[No Abstract] [Full Text] [Related]
39. [Treatment of prostatic carcinoma with phostrolin and bromocriptine while monitoring serum concentrations of testosterone and prolactin].
Jeromin L
Pol Tyg Lek; 1980 Mar; 35(10):359-62. PubMed ID: 7367321
[No Abstract] [Full Text] [Related]
40. Bromocriptine in the treatment of advanced breast cancer.
Barrett A; Morgan L; Raggatt PR; Hobbs JR
Clin Oncol; 1976 Dec; 2(4):373-7. PubMed ID: 1037393
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
